William Charles Bertrand

Insider Reports History

Location
Abingdon, Oxfordshire, United Kingdom
Signature
/s/ William Charles Bertrand
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Charles Bertrand:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARDELYX, INC. Director Common Stock 290,707 $1,052,359 $3.62 18 Jun 2025 Direct
ARDELYX, INC. Director Stock Option (Right to Buy) 54,059 $93,364 $2.32 18 Jun 2025 Direct
Adaptimmune Therapeutics PLC Chief Operating Officer Ordinary Shares with a nominal value of GBP0.001 per share 986,352 $59,181 $0.0600 28 Aug 2025 Direct
Adaptimmune Therapeutics PLC Chief Operating Officer American Depositary Shares representing Ordinary Shares 7,510 $4,362 $0.5808 17 Jan 2025 Direct
Adaptimmune Therapeutics PLC Chief Operating Officer Option to purchase Ordinary Shares 1,074,696 20 Feb 2025 Direct

Insider Reports Filed by William Charles Bertrand

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADAP Adaptimmune Therapeutics PLC 28 Aug 2025 1 -$2,091 4 Chief Operating Officer 29 Aug 2025, 18:25
ARDX ARDELYX, INC. 18 Jun 2025 3 $0 4 Director 23 Jun 2025, 20:38
ADAP Adaptimmune Therapeutics PLC 20 Feb 2025 2 $0 4 Chief Operating Officer 20 Feb 2025, 17:35
ADAP Adaptimmune Therapeutics PLC 17 Jan 2025 1 -$3,243 4 Chief Operating Officer 17 Jan 2025, 21:16
ADAP Adaptimmune Therapeutics PLC 13 Jan 2025 3 -$11,360 4 Chief Operating Officer 15 Jan 2025, 16:15
ARDX ARDELYX, INC. 14 Jun 2024 2 $0 4 Director 17 Jun 2024, 18:52
ADAP Adaptimmune Therapeutics PLC 16 Jan 2024 3 -$16,423 4 Chief Operating Officer 17 Jan 2024, 17:30
ADAP Adaptimmune Therapeutics PLC 15 Jan 2024 2 $0 4 Chief Operating Officer 17 Jan 2024, 17:03
ADAP Adaptimmune Therapeutics PLC 11 Jan 2024 2 -$7,813 4 Chief Operating Officer 12 Jan 2024, 17:00
ARDX ARDELYX, INC. 15 Jun 2023 2 $0 4 Director 16 Jun 2023, 18:29
ADAP Adaptimmune Therapeutics PLC 17 Jan 2023 1 -$8,250 4 Chief Operating Officer 17 Jan 2023, 20:17
ADAP Adaptimmune Therapeutics PLC 17 Jan 2023 3 $0 4 Chief Operating Officer 17 Jan 2023, 20:07
ADAP Adaptimmune Therapeutics PLC 11 Jan 2023 2 -$15,197 4 Chief Operating Officer 12 Jan 2023, 20:03
ADAP Adaptimmune Therapeutics PLC 04 Jan 2023 1 -$6,071 4 Chief Operating Officer 04 Jan 2023, 20:02
ARDX ARDELYX, INC. 15 Jun 2022 2 $0 4 Director 17 Jun 2022, 16:23
ADAP Adaptimmune Therapeutics PLC 18 Jan 2022 1 -$13,942 4 Chief Operating Officer 18 Jan 2022, 20:04
ADAP Adaptimmune Therapeutics PLC 12 Jan 2022 2 $0 4 Chief Operating Officer 13 Jan 2022, 20:00
ADAP Adaptimmune Therapeutics PLC 11 Jan 2022 2 -$21,376 4 Chief Operating Officer 13 Jan 2022, 20:02
ADAP Adaptimmune Therapeutics PLC 04 Jan 2022 1 -$14,184 4 Chief Operating Officer 05 Jan 2022, 20:08
ADAP Adaptimmune Therapeutics PLC 02 Jul 2021 1 -$18,659 4 Chief Operating Officer 02 Jul 2021, 20:01
ARDX ARDELYX, INC. 16 Jun 2021 2 $0 4 Director 21 Jun 2021, 16:11